Terms: = Prostate cancer AND SPOP, TEF2, 8405, ENSG00000121067, O43791 AND Clinical Outcome
5 results:
1. Glycyl-tRNA Synthetase (GARS) Expression Is Associated with prostate cancer Progression and Its Inhibition Decreases Migration, and Invasion In Vitro.
Khosh Kish E; Gamallat Y; Choudhry M; Ghosh S; Seyedi S; Bismar TA
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901698
[TBL] [Abstract] [Full Text] [Related]
2. Long non-coding RNAs correlate with genomic stability in prostate cancer: A clinical outcome and survival analysis.
Jianfeng W; Yutao W; Jianbin B
Genomics; 2021 Sep; 113(5):3141-3151. PubMed ID: 34174340
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Underpinnings Governing Genetic Complexity of ETS-Fusion-Negative prostate cancer.
Bhatia V; Ateeq B
Trends Mol Med; 2019 Nov; 25(11):1024-1038. PubMed ID: 31353123
[TBL] [Abstract] [Full Text] [Related]
4. TRIM28 protects TRIM24 from spop-mediated degradation and promotes prostate cancer progression.
Fong KW; Zhao JC; Song B; Zheng B; Yu J
Nat Commun; 2018 Nov; 9(1):5007. PubMed ID: 30479348
[TBL] [Abstract] [Full Text] [Related]
5. spop regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein.
Geng C; Kaochar S; Li M; Rajapakshe K; Fiskus W; Dong J; Foley C; Dong B; Zhang L; Kwon OJ; Shah SS; Bolaki M; Xin L; Ittmann M; O'Malley BW; Coarfa C; Mitsiades N
Oncogene; 2017 Aug; 36(33):4767-4777. PubMed ID: 28414305
[TBL] [Abstract] [Full Text] [Related]
